Next generation sequencing (NGS) Market by Product & Services (Pre-Sequencing Products & Service, Sequencing Services, Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing), Application (Diagnostics, Drug Discovery), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers) - Analysis & Forecast 2019-2030
Report ID : 3 | Published Date : Jan 2019 | Pages : 150 | Region : Global | Report Code : MD-03
Next generation sequencing (NGS) Market Overview and Introduction
Next generation sequencing (NGS) also known as high-throughput sequencing technique that enables scientists and researchers to sequence and assemble short DNA sequences. Next generation sequencing technologies has brought significant changes in the sequencing process by providing high throughput, speed, flexibility and reduced sequencing cost. NGS can generate hundreds of nucleotide sequence data in a single sequencing run when programmed. The NGS technology has grown rapidly owing to its growing adoption in clinical applications in whole genomes or targeted genomes sequencing. Also the cost of sequencing has reduced leading to usage of next generation sequencing in variety of clinical applications. The NGS technology has clinical applications in field like cancer, inherited genetic disorders, identification of infectious diseases and cancer related disorders.
Next generation sequencing (NGS) Market by Product & Services, Technology, Application, End-Users and Geography
The market for next generation sequencing can be segmented based on product & services, technology, application, end-users and geography. The product segment can be categorized as Pre-Sequencing Products & Services, NGS Consumables, Platforms, & Services for Platforms, Sequencing Services and NGS Data Analysis, Storage, and Management (Bioinformatics). On the basis of technology the market is subdivided into sequencing by synthesis, ion semiconductor sequencing, single molecule real time sequencing, Nanopore Sequencing, and Other Sequencing Technologies. Based on application the market can be categorized into drug discovery, diagnostics and other applications. Based on the end user segment the market can be segmented as hospitals & clinics, Academic Institutes & Research Centers and pharmaceutical and biotechnology companies and other end users.
Next generation sequencing (NGS) Market by Regions
Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (Latin America (LATAM), and Middle East and Africa (MENA). North America accounted for the largest market share of the market followed by Europe. However, during the forecast period Asia-Pacific region is anticipated to record highest growth owing to wide penetration of the technology and technological advancement in NSG, increasing focus on drug discovery initiatives by healthcare and biopharmaceutical companies, investment by pharmaceutical and biotechnology companies in drug discovery are some of the key factors expected to drive the growth of next generation sequencing market.
Next generation sequencing (NGS) Market Prominent Players
Some of the major players operating in the global NGS market are Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.